Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
25% albumin
DRUG
2 trials
Sponsors
McGill University Health Centre/Research Institute of the McGill University Health Centre
, Alexander Flannery, 859-323-4011
Conditions
Other Complications of Liver Transplant
Shock, Septic
Phase 1
Effect of Albumin Administration on Vasopressor Duration in Resolving Septic Shock
Terminated
NCT02716597
Alexander Flannery, 859-323-4011
Shock, Septic
Start: 2016-03-31
End: 2019-01-31
Updated: 2019-04-04
Phase 4
Effect of Hyperoncotic Albumin on Vascular Hemodynamics and Oxygen Delivery Following Orthotopic Liver Transplant
NCT01328132
McGill University Health Centre/Research Institute of the McGill University Health Centre
Other Complications of Liver Transplant
Start: 2011-03-31
End: 2011-10-31
Target: 20
Updated: 2011-04-04